Atorvastatin suppresses oxidized LDL-induced dendritic cell-like differentiation of RAW264.7 cells regulated by the p38 MAPK pathway

Molecular and Cellular Biochemistry

Volumn 371, Issue 1-2, 2012, Pages 105-113

  Hu, Liu Hua ^a   Zhang, Tuo ^a   Shao, Qin ^a   Li, Dan Dan ^a   Jin, Shu Xuan ^a   Nie, Peng ^a   Yi, Jing ^a   He, Ben ^a   Shen, Ling Hong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Atorvastatin; Dendritic cell; Macrophage; Oxidized low density lipoprotein; p38 MAPK

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ATORVASTATIN; CD1D ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE P38; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENDOCYTOSIS; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTIGENS, CD1D; ANTIGENS, CD86; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELLS; DOWN-REGULATION; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPOPROTEINS, LDL; MACROPHAGES; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRROLES; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84868526007     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1427-3     Document Type: Article

References (21)

1. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695
2. Chomarat P, Banchereau J, Davoust J, Palucka AK (2000) IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 1:510-514
3. Perrin-Cocon L, Coutant F, Agaugue S, Deforges S, Andre P, Lotteau V (2000) Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. J Immunol 167:3785-3891
4. Verhasselt V, Buelens C, Willems F, De Groote D, Haeffner-Cavaillon N, Goldman M (1997) Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J Immunol 158:2919-2925
5. Shen LH, Zhou L, Wang BY, Pu J, Hu LH, Chai DJ, Wang Li, Zeng JZ, He B (2008) Oxidized low-density lipoprotein induces differentiation of RAW264.7 murine macrophage cell line into dendritic-like cell. Atherosclerosis 199:257-264
6. Zhou GY, Ge S, Liu DZ, Xu GL, Zhang RL, Yin Q, Zhu W, Chen J, Liu X (2010) Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway. Cardiology 115:221-228
7. Bot I, Jukema JW, Lankhuizen IM, van Berkel TJ, Biessen EA (2011) Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels. Atherosclerosis 214:295-300
8. Tandon V, Bano G, Khajuria V, Parihar A, Gupta S (2005) Pleiotropic effects of statins. Indian J Pharmacol 37:77-85
9. Yilmaz A, Reiss C, Tantawi O, Wenig A, Stumpf C, Raaz D, Ludwig J, Berger T, Steinkasserer A, Daniel WG, Garlichs CD (2004) HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis. Atherosclerosis 172:85-93
10. Yilmaz A, Reiss C, Weng A, Cicha I, Stumpf C, Steinkasserer A, Daniel WG, Garlichs CD (2006) Differential effects of statins on relevant functions of human monocyte-derived dendritic cells. J Leukoc Biol 79:529-538
11. Li M, Liu Y, Dutt P, Fanburg BL, Toksoz D (2007) Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin. Am J Physiol Lung Cell Mol Physiol 293:L463-L471
12. Ozbek E, Cekmen M, Ilbey YO, Simsek A, Polat EC, Somay A (2009) Atorvastatin prevents gentamicin-induced renal damage in rats through the inhibition of p38-MAPK and NF-kappaB pathways. Ren Fail 31:382-392
13. Palinski W (2000) Immunomodulation: a new role for statins? Nat Med 6:1311-1312
14. Banchereau J, Steinman RM (1998) Dendritic cells and control of immunity. Nature 392:245-252
15. Saxena RK, Vallyathan V, Lewis DM (2003) Evidence for lipopolysaccharide-induced differentiation of RAW264.7 murine macrophage cell line into dendritic-like cells. J Biosci 28:129-134
16. 4 but not by DNCB. Toxicol Sci 99:488-501
17. Nakahara T, Moroi Y, Uchi H, Furue M (2006) Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement. J Dermatol Sci 42:1-11
18. Wang WY, Li J, Yang D, Xu W, Zha RP, Wang YP (2010) OxLDL stimulates lipoprotein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways. Cardiovasc Res 85:845-852
19. Cangemi R, Loffredo L, Carnevale R, Perri L, Patrizi MP, Sanguigni V, Pignatelli P, Violi F (2008) Early decrease of oxidative stress by atorvastatin in hypercholesterolemic patients: effect on circulating vitamin E. Eur Heart J 29:54-62
20. Miyazawa M, Ito Y, Kosaka N, Nukada Y, Sakaguchi H, Suzuki H, Nishiyama N (2008) Role of MAPK signaling pathway in the activation of dendritic type cell line, THP-1, induced by DNCB and NiSO4. J Toxicol Sci 33:51-59
21. Nukada Y, Miyazawa M, Kosaka N, Ito Y, Sakaguchi H, Nishiyama N (2008) Production of IL-8 in THP-1 cells following contact allergen stimulation via mitogen-activated protein kinase activation or tumor necrosis factor-alpha production. J Toxicol Sci 33:175-185